European Medicines Agency Recommends Suspension Of Marketing Authorisations For Carisoprodol-containing Medicinal Products
Nov 18th 2007Drug InformationPain / Anesthetics
The European Medicines Agency (EMEA) has recommended the suspension of marketing authorisations for all medicinal products containing carisoprodol. Carisoprodol products are available in 12 Member States under prescription, mainly for the treatment of acute lower back pain. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
